Loading ETF profile…
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | Eli Lilly & Co | 20.34% | $191.53M |
| NVS | Novartis Ag | 10.52% | $99.04M |
| MRK | Merck & Co Inc | 9.84% | $92.65M |
| NVO | Novo Nordisk A/S | 5.37% | $50.57M |
| ABBV | Abbvie Inc | 4.60% | $43.29M |
| PFE | Pfizer Inc | 4.54% | $42.73M |
| BMY | Bristol-Myers Squibb Co | 4.45% | $41.93M |
| GSK | Gsk Plc | 4.42% | $41.59M |
| JNJ | Johnson & Johnson | 4.36% | $41.04M |
| AZN | Astrazeneca Plc | 4.30% | $40.47M |
| MCK | Mckesson Corp | 4.16% | $39.15M |
| SNY | Sanofi Sa/France | 4.02% | $37.89M |
| COR | Cencora Inc | 3.39% | $31.89M |
| HLN | Haleon Plc | 3.05% | $28.77M |
| TEVA | Teva Pharmaceutical Industries Ltd | 2.99% | $28.17M |
| TAK | Takeda Pharmaceutical Co Ltd | 2.84% | $26.79M |
| ZTS | Zoetis Inc | 2.22% | $20.89M |
| VTRS | Viatris Inc | 1.12% | $10.58M |
| JAZZ | Jazz Pharmaceuticals Plc | 1.03% | $9.70M |
| AXSM | Axsome Therapeutics Inc | 0.76% | $7.12M |
| CORT | Corcept Therapeutics Inc | 0.51% | $4.76M |
| — | Other/Cash | 0.37% | $3.44M |
| ELAN | Elanco Animal Health Inc | 0.35% | $3.31M |
| OGN | Organon & Co | 0.23% | $2.15M |
| BHC | Bausch Health Cos Inc | 0.09% | $888.35K |